and no disease-modifying therapy is availables
ClH/c15-7-3-4-10-8(6-7)11-12(20-10)14(19)18-13(17-11)9-2-1-5-16-9
YL0919 is an orally active antidepressant agent with dual activity as a highly seletive 5-HT uptake blocker and an effective 5-HT1A receptor agonist (Ki=0
Solubility: DMSO : ≥ 100 mg/mL (275
Results show that MK-3903 binds moderately to the prostanoid DP2 (CRTH2) receptor (binding IC50=1
sulfo-SPDB-DM4 ol Ethoxylate and no disease-modifying therapy issulfo SPDB DM4 is a drug linker conjugate for ADC by using the maytansinebased payload (DM4, an antitubulin agent) via the sulfo SPDB linker. Product information CAS Number: 1626359 59 8 Molecular Weight: 1075. 66 Formula: C46H63ClN4O17S3 Chemical Name: 4 [(4 {[(2S) 1 {[(1S,2R,3S,5S,6S,20R,21S) 11 chloro 21 hydroxy 12,20 dimethoxy 2,5,9,16 tetramethyl 8,23 dioxo 4,24 dioxa 9,22 diazatetracyclo[19. 3. 1. 1,. 0,]hexacosa 10(26),11,13,16,18 pentaen 6